The antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cells.

MCF-7 T-47D antitumor agent cancer treatment natural anticancer tumor suppressor

Journal

Breast cancer (Dove Medical Press)
ISSN: 1179-1314
Titre abrégé: Breast Cancer (Dove Med Press)
Pays: New Zealand
ID NLM: 101591856

Informations de publication

Date de publication:
2019
Historique:
entrez: 13 3 2019
pubmed: 13 3 2019
medline: 13 3 2019
Statut: epublish

Résumé

Black cohosh (BC) is an herbal remedy often used by women to treat symptoms associated with menopause. Research has shown that the molecular activity of BC is associated with estrogen receptor alpha (ER-α) regulation. Progesterone receptor (PR) expression is found to be consistent with ER expression and mutations in the The objective of this study was to determine the effects of BC alone, as well as in combination with hormones and antihormones, on cell viability and expression of ER-α, PR, and BRCA1 in both T-47D and MCF-7 cell lines. Cells were cultured in charcoal-stripped serum prior to their treatment and subsequent protein extraction. Western blot analyses were performed following a Bio-Rad Bradford protein assay and SDS-PAGE gel electrophoresis, with ECL luminescence and Image Studio Lite software. Cellular viability assays were performed using propidium iodine (PI) staining, and the distribution of fluorescent structures was evaluated through confocal microscopy. RT-qPCR analysis was performed on extracted cellular RNA. All statistical analyses were performed using SPSS software, and data was subjected to Kruskal-Wallis testing, followed by post-hoc analysis using the Mann-Whitney U-test to determine the statistical significance of all findings. Western blot analysis displayed significant alterations of ER-α, PR, and BRCA1 protein levels after 24-hour treatment with 80-500 μM BC. BC displayed a concentration-dependent decrease on ER-α and BRCA1 expression, with an 87% reduction of ER-α expression and a 43% of BRCA1 expression in T-47D cells compared to control. After six days of treatment with 400 μM BC, a 50% decrease in cell proliferation was observed. Following 24 hours of co-treatment with 400 μM BC and 10 nM E Black Cohosh demonstrates substantial anti-cancer properties, and this study may significantly aid in the understanding of the molecular effects of BC on ER-α, PR, and BRCA1 in breast cancer cells.

Sections du résumé

BACKGROUND BACKGROUND
Black cohosh (BC) is an herbal remedy often used by women to treat symptoms associated with menopause. Research has shown that the molecular activity of BC is associated with estrogen receptor alpha (ER-α) regulation. Progesterone receptor (PR) expression is found to be consistent with ER expression and mutations in the
PURPOSE OBJECTIVE
The objective of this study was to determine the effects of BC alone, as well as in combination with hormones and antihormones, on cell viability and expression of ER-α, PR, and BRCA1 in both T-47D and MCF-7 cell lines.
METHODS METHODS
Cells were cultured in charcoal-stripped serum prior to their treatment and subsequent protein extraction. Western blot analyses were performed following a Bio-Rad Bradford protein assay and SDS-PAGE gel electrophoresis, with ECL luminescence and Image Studio Lite software. Cellular viability assays were performed using propidium iodine (PI) staining, and the distribution of fluorescent structures was evaluated through confocal microscopy. RT-qPCR analysis was performed on extracted cellular RNA. All statistical analyses were performed using SPSS software, and data was subjected to Kruskal-Wallis testing, followed by post-hoc analysis using the Mann-Whitney U-test to determine the statistical significance of all findings.
RESULTS RESULTS
Western blot analysis displayed significant alterations of ER-α, PR, and BRCA1 protein levels after 24-hour treatment with 80-500 μM BC. BC displayed a concentration-dependent decrease on ER-α and BRCA1 expression, with an 87% reduction of ER-α expression and a 43% of BRCA1 expression in T-47D cells compared to control. After six days of treatment with 400 μM BC, a 50% decrease in cell proliferation was observed. Following 24 hours of co-treatment with 400 μM BC and 10 nM E
CONCLUSION CONCLUSIONS
Black Cohosh demonstrates substantial anti-cancer properties, and this study may significantly aid in the understanding of the molecular effects of BC on ER-α, PR, and BRCA1 in breast cancer cells.

Identifiants

pubmed: 30858726
doi: 10.2147/BCTT.S181730
pii: bctt-11-099
pmc: PMC6385778
doi:

Types de publication

Journal Article

Langues

eng

Pagination

99-110

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Cancer. 2000 Aug 15;89(4):817-25
pubmed: 10951345
J Steroid Biochem Mol Biol. 2001 May;77(2-3):97-108
pubmed: 11377974
J Cell Physiol. 2003 Jul;196(1):19-41
pubmed: 12767038
Life Sci. 2003 Jul 25;73(10):1215-29
pubmed: 12850238
Trends Endocrinol Metab. 2005 Jul;16(5):214-21
pubmed: 15927480
Cancer Res. 2006 Jan 1;66(1):41-5
pubmed: 16397213
BMC Pharmacol. 2007 Sep 20;7:11
pubmed: 17880733
Phytomedicine. 2008 Jun;15(6-7):504-11
pubmed: 17980565
Cancer. 2008 May 15;112(10):2130-42
pubmed: 18383519
Pharmacol Res. 2008 Jul;58(1):8-14
pubmed: 18585461
Am J Obstet Gynecol. 2008 Nov;199(5):455-66
pubmed: 18984078
Breast Cancer Res. 2010;12(1):R12
pubmed: 20149218
Maturitas. 2010 Aug;66(4):333-43
pubmed: 20580501
Syst Biol Reprod Med. 2011 Dec;57(6):279-87
pubmed: 22077725
Int J Biol Sci. 2014 May 14;10(5):566-75
pubmed: 24910535
Future Oncol. 2014 Nov;10(14):2293-301
pubmed: 25471040
Lancet Oncol. 2015 Feb;16(2):137-8
pubmed: 25638678
Horm Mol Biol Clin Investig. 2010 Aug 1;2(1):211-7
pubmed: 25961194
Indian J Surg. 2015 Apr;77(2):141-6
pubmed: 26139969
Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):557-68
pubmed: 26303083
Nature. 2015 Nov 19;527(7578):S101
pubmed: 26580154
Asian Spine J. 2016 Aug;10(4):787-91
pubmed: 27559463
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Genes Cancer. 2016 Nov;7(11-12):414-425
pubmed: 28191286
Breast Cancer (Dove Med Press). 2018 Jan 18;10:1-11
pubmed: 29403307
J Steroid Biochem. 1985 Jul;23(1):87-94
pubmed: 4021494

Auteurs

Michael Crone (M)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Kelly Hallman (K)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Victoria Lloyd (V)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Monica Szmyd (M)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Briana Badamo (B)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Mia Morse (M)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Sumi Dinda (S)

Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.
Institute for Stem Cell and Regenerative Medicine and Center of Biomedical Sciences, Oakland University, Rochester, MI 48309-4476, USA, sdinda@oakland.edu.

Classifications MeSH